High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
Biswajit Naik, Nidhi Gupta, Rupal Ojha, Satyendra Singh, Vijay Kumar Prajapati, Dhaneswar Prusty
Topics & Concepts
DruggabilityVirtual screeningADMENatural productSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug discoveryIn silicoDocking (animal)Computational biologyCoronavirus disease 2019 (COVID-19)DrugPandemicPharmacologyChemistryBiologyMedicineBioinformaticsBiochemistryInfectious disease (medical specialty)NursingDiseaseGenePathologyComputational Drug Discovery MethodsSynthesis and biological activitySARS-CoV-2 and COVID-19 Research